Central Nervous System (CNS) infections continue to be a global health concern, with emerging trends reshaping the landscape of these debilitating conditions. The increasing globalization of travel and trade facilitates the rapid spread of infectious agents, transcending geographical boundaries. Globalization, combined with factors like climate change and antimicrobial resistance, introduces new challenges in the prevention, diagnosis, and treatment of CNS infections. Neurological complications associated with viral infections, such as Zika and West Nile viruses, have gained prominence in recent years. These infections highlight the need for heightened surveillance and research to understand the long-term consequences on the nervous system. Additionally, the threat of emerging infectious diseases, as exemplified by the COVID-19 pandemic, underscores the importance of preparedness and rapid response in the face of evolving health crises. International collaboration is essential in addressing the global impact of CNS infections. Shared research, data, and resources contribute to a better understanding of regional variations in disease prevalence and outcomes. Furthermore, efforts to improve healthcare infrastructure, particularly in resource-limited settings, are critical to ensuring equitable access to diagnostics and treatment for CNS infections on a global scale.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain